Anıl Kubaloglu1, Esin Sogutlu Sari2, Arif Koytak3. 1. Ophthalmology Department, Yeni Yuzyıl University Faculty of Medicine and Dunya Eye Hospital, Istanbul, Turkey. 2. Ophthalmology Department, Faculty of Medicine, Bursa Uludag University, Görükle - Bursa, Turkey. dresinsogutlu@gmail.com. 3. Ophthalmology Department, Faculty of Medicine, Bezmialem Vakıf University, Istanbul, Turkey.
Abstract
PURPOSE: To evaluate the 3-year results of deep anterior lamellar keratoplasty (DALK) using the big-bubble technique in keratoconus patients with previous corneal collagen crosslinking (CXL) treatment. METHODS: Twenty eyes of 20 keratoconus patients who underwent DALK surgery using the big-bubble technique after CXL treatment between January 2011 and September 2015 were retrospectively reviewed. All patients completed 3 years follow-up. Intraoperative and postoperative complications were recorded. Uncorrected visual acuity (UCVA), best spectacle corrected visual acuity (BSCVA), maximum keratometry, keratometric astigmatism and endothelial cell density (ECD) were analysed. RESULTS: The mean interval between CXL and DALK surgery was 47.5 ± 24.0 months (mean ± SD). DALK was completed in all eyes. Big-bubble was successfully achieved in 16 eyes (80%), and manual dissection was performed in four eyes (20%). Microperforation occurred in three eyes (15%). Postoperatively, persistent epithelial defect occurred in three eyes (15%). The mean UCVA and mean BSCVA values were significantly improved preoperatively to all postoperative visits (p < 0.001). UCVA was 20/100 or lower in all eyes preoperatively and 20/100 or better in 18 eyes (80%) at 3 years; BSCVA was 20/40 or better in all eyes (100%) and 20/20 or better in three eyes (15%), and keratometric astigmatism was lower than 4 dioptres in 14 eyes (70%) at 3 years. The mean ECD loss was 6.3 ± 4.4% at 1 year, 9.0 ± 6.3% at 2 years and 11.2 ± 7.4% at 3 years. CONCLUSION: Previous CXL treatment in keratoconus patients did not cause a negative impact on the visual, refractive and surgical outcomes of DALK surgery using the big-bubble technique. DALK surgery seems to be a safe and effective surgical approach in these patients.
PURPOSE: To evaluate the 3-year results of deep anterior lamellar keratoplasty (DALK) using the big-bubble technique in keratoconuspatients with previous corneal collagen crosslinking (CXL) treatment. METHODS: Twenty eyes of 20 keratoconuspatients who underwent DALK surgery using the big-bubble technique after CXL treatment between January 2011 and September 2015 were retrospectively reviewed. All patients completed 3 years follow-up. Intraoperative and postoperative complications were recorded. Uncorrected visual acuity (UCVA), best spectacle corrected visual acuity (BSCVA), maximum keratometry, keratometric astigmatism and endothelial cell density (ECD) were analysed. RESULTS: The mean interval between CXL and DALK surgery was 47.5 ± 24.0 months (mean ± SD). DALK was completed in all eyes. Big-bubble was successfully achieved in 16 eyes (80%), and manual dissection was performed in four eyes (20%). Microperforation occurred in three eyes (15%). Postoperatively, persistent epithelial defect occurred in three eyes (15%). The mean UCVA and mean BSCVA values were significantly improved preoperatively to all postoperative visits (p < 0.001). UCVA was 20/100 or lower in all eyes preoperatively and 20/100 or better in 18 eyes (80%) at 3 years; BSCVA was 20/40 or better in all eyes (100%) and 20/20 or better in three eyes (15%), and keratometric astigmatism was lower than 4 dioptres in 14 eyes (70%) at 3 years. The mean ECD loss was 6.3 ± 4.4% at 1 year, 9.0 ± 6.3% at 2 years and 11.2 ± 7.4% at 3 years. CONCLUSION: Previous CXL treatment in keratoconuspatients did not cause a negative impact on the visual, refractive and surgical outcomes of DALK surgery using the big-bubble technique. DALK surgery seems to be a safe and effective surgical approach in these patients.
Entities:
Keywords:
Corneal collagen crosslinking; Deep anterior lamellar keratoplasty; Keratoconus
Authors: Bart T H van Dooren; Paul G H Mulder; Carla P Nieuwendaal; W Houdijn Beekhuis; Gerrit R J Melles Journal: Am J Ophthalmol Date: 2004-03 Impact factor: 5.258
Authors: Daphne C Y Han; Jodhbir S Mehta; Yong Ming Por; Hla Myint Htoon; Donald T H Tan Journal: Am J Ophthalmol Date: 2009-07-09 Impact factor: 5.258
Authors: Friederike Schaub; Philip Enders; Björn O Bachmann; Ludwig M Heindl; Claus Cursiefen Journal: Graefes Arch Clin Exp Ophthalmol Date: 2017-01-30 Impact factor: 3.117
Authors: Raneen Shehadeh Mashor; Dan B Rootman; Irit Bahar; Neera Singal; Allan R Slomovic; David S Rootman Journal: Can J Ophthalmol Date: 2011-08-04 Impact factor: 1.882